It promotes CYTB translation within mitochondria [61] and may target several nuclear-encoded genes, including the tumor suppressor PTEN [62] and RECK, a glycoprotein that negatively regulates matrix metalloproteinases, thus suppressing cancer invasion and metastasis [63]. The gene discussed is MT-CYB; the disease is cancer.